制药ETF投资于参与研究，开发，制造，销售或分销所有类型的药品和药物的公司股票
* 资产及平均交易量 截至 2022-06-23 16：18 EDT
ESG,
| Symbol | ETF Name | ESG Score | ESG Score Peer Percentile (%) | ESG Score Global Percentile (%) | Carbon Intensity (Tons of CO2e / $M Sales) | Sustainable Impact Solutions (%) |
|---|---|---|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | 7.03 | 64.65% | 49.10% | 24.6 | 15.61% |
| IHE | iShares U.S. Pharmaceuticals ETF | 4.07 | 10.93% | 9.82% | 29.41 | 9.44% |
| PJP | Invesco Dynamic Pharmaceuticals ETF | 5.49 | 21.86% | 28.84% | 29.86 | 36.21% |
| XPH | SPDR S&P Pharmaceuticals ETF | 6.34 | 32.79% | 39.05% | 36.75 | 16.74% |
| KURE | KraneShares MSCI All China Health Care Index ETF | 4.8 | 44.44% | 22.94% | 63.42 | 11.88% |
| POTX | Global X Cannabis ETF | 0.0 | N/A | N/A | N/A | N/A |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 6.58 | 41.40% | 41.93% | 21.79 | 20.65% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X Shares | 6.04 | 28.57% | 35.51% | 35.74 | 8.20% |
| CHIH | Global X MSCI China Health Care ETF | 6.59 | 42.33% | 42.14% | 78.91 | 17.46% |
| CHNA | Loncar China BioPharma ETF | 6.21 | 74.84% | 37.42% | 79.35 | 12.12% |
| CHB | Global X China Biotech Innovation ETF | 2.5 | 8.82% | 3.46% | 50.26 | 24.31% |
| PSYK | PSYK ETF | 5.84 | 24.65% | 32.88% | 33.63 | 17.97% |
股息、持股
Subscribe to get access
Read more of this content when you subscribe today.
持股
Subscribe to get access
Read more of this content when you subscribe today.
Enjoyed this article? Sign up for our newsletter to receive regular insights and stay connected.